Danaher Declares Quarterly Dividend, Affirms Commitment to Healthcare Innovation and Shareholder Returns

Danaher Corporation Reinforces Commitment to Shareholders and Health Innovations

Danaher Corporation, a leader in the life sciences and diagnostic sectors, announces the approval of a regular quarterly cash dividend of $0.40 per share by its Board of Directors. This dividend, set to be payable on April 24, 2026, to shareholders on record by March 27, 2026, reflects the company's strong financial performance and commitment to shareholder returns. Danaher’s steady dividend policy reinforces its position as a reliable entity in the highly competitive life sciences landscape, where innovation and financial stability are crucial.

The company dedicates itself to harnessing the power of science and technology to enhance human health. Through advanced research and development initiatives, Danaher prioritizes the delivery of solutions that enable faster and more accurate diagnoses across various medical conditions. This focus on innovation not only aims to improve the accuracy of medical interventions but also plays a vital role in decreasing the time and cost involved in developing life-altering therapies. By collaborating closely with customers in healthcare, Danaher addresses pivotal health challenges that impact patients globally, reinforcing its mission to better health outcomes.

With a robust workforce of approximately 60,000 associates, Danaher emphasizes scientific excellence and continuous improvement in its operations. The company is not only focused on immediate health advancements but also strategically positions itself to contribute to a healthier and more sustainable future. Danaher's ongoing investments in innovative technologies and solutions underscore its dedication to enhancing the quality of life for billions while fostering long-term health benefits across communities worldwide.

In addition to its commitment to innovation and shareholder returns, Danaher shares insights about its operational strategies and impact through its official website, www.danaher.com. The recent announcement of the dividend aligns with the company’s long-term objectives, illustrating a balanced approach to shareholder satisfaction and a dedication to advancing healthcare innovation. Through these efforts, Danaher aims to ensure a sustainable future for medical advancements and the well-being of global populations.